Related Experiment Video
Updated: Jan 30, 2026

Dosage-Adjusted Resistance Training in Mice with a Reduced Risk of Muscle Damage
Published on: August 31, 2022
Nirmatrelvir/ritonavir use reduces risk for long COVID in patients with immunodeficiency
Karen M Gilbert1, Mostafa Aglan2, Aditi Jogdand3
1Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA, USA.
Abstract:
Our retrospective study highlights that acute use of nirmatrelvir/ritonavir significantly reduces the risk of post-acute sequelae of SARS-CoV-2 infection (long COVID) in immunodeficient patients, emphasizing the need for clinical trials that include this high-risk population.
More Related Videos
05:19A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance
Published on: November 7, 2025
05:32Povidone Iodine Rectal Preparation at Time of Prostate Needle Biopsy is a Simple and Reproducible Means to Reduce Risk of Procedural Infection
Published on: September 21, 2015
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Relative Risk
Reducing Line Loss
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Adaptations that Reduce Water Loss